Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hypothalamic—pituitary—adrenal

Oral, laryngeal, pharyngeal irritation, fungal infections, suppression of hypothalamic-pituitary-adrenal (HPA) function... [Pg.339]

Ritchie, JC and Nemeroff, CB (1991) Stress, the hypothalamic-pituitary-adrenal axis and depression. In Stress, Neuropeptides and Systemic Disease (Eds McCubbin, JA, Kaufmann, PG and Nemeroff, CB), Academic Press, London, pp. 181-197. [Pg.451]

Glucocorticoid doses of less than 7.5 mg/day of prednisone (or its equivalent) for fewer than 3 weeks generally would not be expected to lead to suppression of the hypothalamic-pituitary-adrenal axis. [Pg.685]

ACTH, adrenocorticotropic hormone or corticotropin FDA, Food and Drug Administration HPA, hypothalamic-pituitary-adrenal IV, intravenously. aThe 250 meg dose has also been administered intramuscularly in an outpatient setting. The 1 meg dose is not FDA-approved. [Pg.689]

ACTH, adrenocorticotropic hormone or corticotropin HPA, hypothalamic-pituitary-adrenal. [Pg.698]

It is important to remember that adverse effects of topical corticosteroids may be systemic in nature and hypothalamic-pituitary-adrenal axis suppression can occur, especially when high-potency corticosteroids are used. Infants and small children may be more susceptible due to their increased skin sur-face body mass ratio.18 Topical corticosteroids may also cause striae, skin atrophy, acne, telangiectasias, and rosacea.2,10,18 Atrophy can result in thin, fragile, easily lacerated skin. Striae are caused by tearing of dermal connective tissue and are irreversible.18 Due to their significant adverse-effect profile, it has been recommended that no topical corticosteroid be used regularly for more than 4 weeks without review and reassessment.2... [Pg.953]

Topical corticosteroids Monitor for skin thinning, telangiec-tasias, and possible hypothalamic-pituitary-adrenal axis suppression. [Pg.957]

Hypothalamic-pituitary-adrenal (HPA) axis A neuroendocrine feedback loop that controls response to stress. [Pg.1568]

Roy, A., Pickar, D., Dejong, J., Karoum, F. Linnoila, M. (1998). Norepinephrine and its metabolites in cerebrospinal fluid, plasma and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch. Gen. Psychiatry, 45, 849-57. [Pg.83]

Stress Hormones 5.1.1. Hypothalamic-Pituitary-Adrenal Axis... [Pg.89]

Imura, H and Fukata, J., Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation. Eur. J. Endocrinol. 130,32-37 (1994). [Pg.118]

R5. Reincke, M Allolio, B., Wurth, G and Winkelmann, W., The hypothalamic-pituitary-adrenal axis in critical illness Response to dexamethasone and corticotropin releasing hormone. J. Clin. Endocrinol. Metab. 77,151-156 (1993). [Pg.126]

RIO. Rivier, C., Chizzonite, R and Vale, W., In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125,2800-2805 (1989). [Pg.126]

However, nicotine also has been shown to stimulate the hypothalamic-pituitary-adrenal axis in rodents, leading to elevated plasma levels of adrenocorticotropic hormone and corticosterone (Andersson et al. 1983 Cam et al. 1979), which are known to exert a wake-promoting effect. However, studies in humans have shown that only intense smoking is able to activate the hypothalamic-pituitary-adrenal axis (Gilbert et al. 1992 Kirschbaum et al. 1992). Nicotine patches, in addition to their use in nicotine suppression and craving, have been used to explore the relationship between sleep and nicotine in human... [Pg.448]

Hypothalamic-Pituitary-Adrenal (HPA) axis An integrated neuroendocrine system linking the hypothalamus (noradrenaline and corticotropin-releasing factor CRF) with the anterior pituitary (corticotropin or ACTH) and the adrenal cortex (cortisol). [Pg.243]

The cortical-hypothalamic-pituitary-adrenal axis has been implicated in major depression 893... [Pg.887]

In depressed patients, cortical-hypothalamic-pituitary-adrenal axis hyperactivity can be explained by the hypersecretion of CRF, and secondary pituitary and adrenal gland hypertrophy. Impaired negative feedback at various CNS sites, including the hippocampus and pituitary are also likely to contribute. Downregulation of hippocampal mineralocorticoid receptors and expression is reported in depressed suicides [50]. In bipolar disorder, hyperactivity of the cortical-hypothalamic-pituitary-adrenal axis has been observed [51]. This increase in cortical-hypothalamic-pituitary-adrenal axis activity has also been observed in mixed mood states, mania and in depression in rapidcycling patients. Partial reversal of HPA overactivity is associated with treatment and recovery from depression. [Pg.893]


See other pages where Hypothalamic—pituitary—adrenal is mentioned: [Pg.446]    [Pg.321]    [Pg.466]    [Pg.542]    [Pg.220]    [Pg.571]    [Pg.608]    [Pg.688]    [Pg.691]    [Pg.699]    [Pg.757]    [Pg.764]    [Pg.930]    [Pg.932]    [Pg.88]    [Pg.118]    [Pg.317]    [Pg.320]    [Pg.13]    [Pg.175]    [Pg.175]    [Pg.215]    [Pg.888]    [Pg.893]   


SEARCH



Adrenalitis

Adrene

Hypothalamic

Pituitary

© 2024 chempedia.info